AKT1 and carcinoma: Indeed, VEGF binding to VEGFR-2 activates AKT-mediated cell survival signals [221]: this would increase the viability of circulating OSCC cells, protecting them from anoikis, as has been reported for other carcinoma cell types [135,136] (Table 1).